( S ) Few studies of medical therapies for endometriosis report outcomes that are relevant to patients , and many women gain only limited or intermittent benefit from treatment
OBJECTIVE To assess patient response rates to medical therapies used to treat endometriosis-associated pain .
Letrozole and norethisterone acetate in rectovaginal endometriosis.
This open-label prospect i ve study evaluated the efficacy of letrozole ( 2.5 mg/day ) combined with norethisterone acetate ( 2.5 mg/day ) in the treatment of  pain symptoms related to the presence of rectovaginal endometriosis . The treatment significantly and quickly decreased the intensity of symptoms , but pain recurred at 3-month follow-up ; five women underwent surgery during the follow-up , and histologic examination of rectovaginal nodules revealed the presence of active endometriotic lesions
( S ) Few studies of medical therapies for endometriosis report outcomes that are relevant to patients , and many women gain only limited or intermittent benefit from treatment
OBJECTIVE To assess patient response rates to medical therapies used to treat endometriosis-associated pain .